Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSouth32 Limited Regulatory News (S32)

Share Price Information for South32 Limited (S32)

Share Price is delayed by 15 minutes
Get Live Data
244.00    2.60 (1.08%)
Bid:
243.60
Ask:
244.00
Spread: 0.40 (0.164%)
Market Cap: £10.92b
S32 Live PriceLast checked at - London Stock Exchange

Intraday South32 Limited Share Chart

Half Year Results Presentation

17 Feb 2022 07:01

RNS Number : 9817B
South32 Limited
17 February 2022
 

South32 Limited

(Incorporated in Australia under the Corporations Act 2001 (Cth))

(ACN 093 732 597)

ASX / LSE / JSE Share Code: S32 ADR: SOUHY

ISIN: AU000000S320

south32.net

 

17 February 2022

 

 

 

2022 HALF YEAR FINANCIAL RESULTS PRESENTATION

The following presentation has today been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism:

· South32 Limited - 2022 Half Year Financial Results

South32 Limited (ASX, LSE, JSE: S32; ADR: SOUHY) (South32) held a conference call at 8.30am Australian Western Standard Time to discuss the presentation materials. The conference call recording is available on the South32 website (https://www.south32.net/investors-media/investor-centre/financial-operational-results).

Separately a video presentation by South32 Chief Executive Officer, Graham Kerr, will be made available on the South32 website (https://www.south32.net/investors-media/investor-centre/financial-operational-results).

 

About South32

South32 is a globally diversified mining and metals company. Our purpose is to make a difference by developing natural resources, improving people's lives now and for generations to come. We are trusted by our owners and partners to realise the potential of their resources. We produce bauxite, alumina, aluminium, metallurgical coal, manganese, nickel, silver, lead and zinc at our operations in Australia, Southern Africa and South America. With a focus on growing our base metals exposure, we also have two development options in North America and several partnerships with junior explorers around the world.

 

Further Information

Investor Relations

Alex VolanteT +61 8 9324 9029M +61 403 328 408E Alex.Volante@south32.net

Tom GallopT +61 8 9324 9030M +61 439 353 948E Tom.Gallop@south32.net

Media Relations

Miles GodfreyM +61 415 325 906E Miles.Godfrey@south32.net

Jenny WhiteT +44 20 7798 1773M +44 7900 046 758E Jenny.White@south32.net

 

Further information on South32 can be found at www.south32.net.

JSE Sponsor: UBS South Africa (Pty) Ltd17 February 2022

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCQDLBFLLLBBBL
Date   Source Headline
12th May 20238:06 amRNSDaily Share Buy-Back Notice
11th May 20238:07 amRNSDaily Share Buy-Back Notice
9th May 20237:00 amRNSHermosa Project Update
9th May 20237:00 amRNSDaily Share Buy-Back Notice
5th May 20238:21 amRNSDaily Share Buy-Back Notice
4th May 20238:11 amRNSDaily Share Buy-Back Notice
3rd May 20237:52 amRNSDaily Share Buy-Back Notice
2nd May 20237:04 amRNSDaily Share Buy-Back Notice
2nd May 20237:00 amRNSInitial Director's Interest Notice
2nd May 20237:00 amRNSTotal Voting Rights
2nd May 20237:00 amRNSInitial Director's Interest Notice
2nd May 20237:00 amRNSDaily Share Buy-Back Notice
28th Apr 20238:17 amRNSDaily Share Buy-Back Notice
27th Apr 20237:22 amRNSDaily Share Buy-Back Notice
24th Apr 20237:00 amRNSQuarterly Report - March 2023
21st Apr 20238:23 amRNSDaily Share Buy-Back Notice
20th Apr 20238:03 amRNSDaily Share Buy-Back Notice
19th Apr 20238:05 amRNSDaily Share Buy-Back Notice
18th Apr 20237:48 amRNSDaily Share Buy-Back Notice
17th Apr 20238:14 amRNSDaily Share Buy-Back Notice
14th Apr 20238:12 amRNSDaily Share Buy-Back Notice
13th Apr 20239:00 amRNSSouth32 Board Changes
13th Apr 20238:42 amRNSNotification of Securities
13th Apr 20238:26 amRNSDaily Share Buy-Back Notice
12th Apr 20238:23 amRNSDaily-Share Buy-Back Notice
6th Apr 20238:07 amRNSDaily Share Buy-Back Notice
5th Apr 20239:17 amRNSDaily Share Buy-Back Notice
4th Apr 20239:18 amRNSDaily Share-Buy Back Notice
3rd Apr 20238:48 amRNSTotal Voting Rights and Issued Capital
3rd Apr 20238:23 amRNSDaily Share-Buy Back Notice
30th Mar 20237:40 amRNSDaily Share Buy-Back Notice
29th Mar 20238:07 amRNSDaily Share Buy-Back Notice
28th Mar 20238:26 amRNSDaily Share Buy-Back Notice
27th Mar 20237:51 amRNSDaily Share Buy-Back Notice
24th Mar 20238:22 amRNSDaily Share Buy-Back Notice
23rd Mar 20238:11 amRNSDaily Share Buy-Back Notice
21st Mar 20237:53 amRNSDaily Share Buy-Back Notice
20th Mar 20238:09 amRNSDaily Share Buy Back Notice
17th Mar 20238:21 amRNSDaily Share Buy-Back Notice
16th Mar 20238:58 amRNS2023 Interim Dividend Currency Exchange Rates
16th Mar 20238:44 amRNSUpdate to the Notification of Dividend
16th Mar 20238:20 amRNSDaily Share Buy-Back Notice
15th Mar 20238:04 amRNSDaily Share Buy-Back Notice
14th Mar 20237:47 amRNSDaily Share Buy-Back Notice
13th Mar 20238:24 amRNSDaily Share Buy-Back Notice
10th Mar 20238:32 amRNSDaily Share Buy-Back Notice
9th Mar 20238:17 amRNSNotification of Dealing Form
9th Mar 20238:05 amRNSChange of Director's Interest Notice
8th Mar 20238:05 amRNSDaily Share Buy-Back Notice
6th Mar 20238:40 amRNSDaily Share Buy-Back Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.